The Cancer Letter

Inside information on cancer research and drug development

In Brief

NCI names 11 winners of its Cancer Clinical Investigator Team Leadership Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

NCI recognized 11 investigators nationwide with its Cancer Clinical Investigator Team Leadership Awards.

The awards support clinical investigators at NCI-designated cancer centers who participate in NCI-funded clinical trials. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. The award provides partial salary support for 2 years for the recipient to engage in activities and efforts related to the award.

The 2015 recipients are:

  • Leora Horn, of Vanderbilt-Ingram Cancer Center
  • David Hyman, of Memorial Sloan-Kettering Cancer Center
  • Matthew Katz, of MD Anderson Cancer Center
  • Edward Kim, of UC Davis Comprehensive Cancer Center
  • Frederick Lansigan, of Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
  • Charles Leath III, of University of Alabama at Birmingham Comprehensive Cancer Center
  • Elizabeth Plimack, of Fox Chase Cancer Center
  • Andrew Poklepovic, of Massey Cancer Center at Virginia Commonwealth University
  • Yvonne Saenger, of Columbia University’s Herbert Irving Comprehensive Cancer Center
  • Emma Scott, of Oregon Health & Science University Knight Cancer Institute
  • Liza Villaruz, of the University of Pittsburgh Cancer Institute

For details of the 2016 program announcement, open through Dec. 4, visit the NCI website.

Table of Contents

YOU MAY BE INTERESTED IN

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
By Melinda Krigel
Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
By NRG Staff
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account